Policy Briefs on THE
ECONOMIC IMPACT OF HIV
Brief 17: The Economics of HIV and of HIV Programmes in the Era of Covid-19
By Markus Haacker, Kate Harris, Jeffrey Eaton, Geoff Garnett, Gesine Meyer-Rath
December 2020
Key Points
A FRAMEWORK FOR CONSIDERING THE IMPACT OF COVID-19 ON THE ECONOMICS OF HIV
The Covid-19 pandemic has profound negative implications for the economies of countries most affected by HIV, as well as for donor countries that support the global HIV response. It undermines underlying economic fundamentals and adds considerations for HIV policymaking. This paper explores three interrelated ways in which the Covid-19 pandemic and the response to Covid-19 affect people living with HIV and the HIV response: (1) the health impacts of those living with or at risk of acquiring HIV; (2) healthcare capacity challenges; and (3) the consequences for domestic and global financing for HIV.
Summary Briefs
The summary briefs provide an overview of three main areas of economic impact.
Master Slide Set
Policy Briefs
The policy briefs provide more detail on the evidence available on each of the topics.
1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality
2. Increased Health and Life Prospects and Their Economic Valuation
3. HIV, Population Dynamics and the Labour Force
4. Human Capital
5. Capital and Investment
6. Productivity and Employment of People Living with HIV
7. Economic Growth – Overview
8. Interactions Between HIV and Poverty
9. Disease Burden Across Population Sub-Groups
10. Trade-offs between Allocation to Health and Other Sectors
11. Domestic Public Funding for HIV
12. Trade-offs and Synergies between HIV and Other Health Objectives
13. Assessing Cost Effectiveness Across HIV and Health Interventions
14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding
15. Public and Private Provision of Health and HIV Services
16. Trade-offs within the HIV Budget
17. The Economics of HIV and of HIV Programmes in the Era of Covid-19
Technical Briefs
The technical briefs provide more detail on the evidence available on each of the topics.
1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality
2. Increased Health and Life Prospects and Their Economic Valuation
3. HIV, Population Dynamics and the Labour Force
4. Human Capital
5. Capital and Investment
6. Productivity and Employment of People Living with HIV
7. Economic Growth – Overview
8. Interactions Between HIV and Poverty
9. Disease Burden Across Population Sub-Groups
10. Trade-offs between Allocation to Health and Other Sectors
11. Domestic Public Funding for HIV
12. Trade-offs and Synergies between HIV and Other Health Objectives
13. Assessing Cost Effectiveness Across HIV and Health Interventions
14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding
15. Public and Private Provision of Health and HIV Services
16. Trade-offs within the HIV Budget
17. The Economics of HIV and of HIV Programmes in the Era of Covid-19
Wits Health Consortium, University of the Witwatersrand